[go: up one dir, main page]

DE60129799D1 - Verfahren zur steigerung des haarwuchses durch wnt polypeptid - Google Patents

Verfahren zur steigerung des haarwuchses durch wnt polypeptid

Info

Publication number
DE60129799D1
DE60129799D1 DE60129799T DE60129799T DE60129799D1 DE 60129799 D1 DE60129799 D1 DE 60129799D1 DE 60129799 T DE60129799 T DE 60129799T DE 60129799 T DE60129799 T DE 60129799T DE 60129799 D1 DE60129799 D1 DE 60129799D1
Authority
DE
Germany
Prior art keywords
hair growth
wnt polypeptide
wnt
increasing hair
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60129799T
Other languages
English (en)
Other versions
DE60129799T2 (de
Inventor
Jiro Kishimoto
Robert Burgeson
Bruce A Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Application granted granted Critical
Publication of DE60129799D1 publication Critical patent/DE60129799D1/de
Publication of DE60129799T2 publication Critical patent/DE60129799T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0627—Hair cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60129799T 2000-03-31 2001-03-30 Verfahren zur steigerung des haarwuchses durch wnt polypeptid Expired - Lifetime DE60129799T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19377100P 2000-03-31 2000-03-31
US193771P 2000-03-31
US26169001P 2001-01-12 2001-01-12
US261690P 2001-01-12
PCT/US2001/010164 WO2001074164A1 (en) 2000-03-31 2001-03-30 Methods of modulating hair growth

Publications (2)

Publication Number Publication Date
DE60129799D1 true DE60129799D1 (de) 2007-09-20
DE60129799T2 DE60129799T2 (de) 2008-04-30

Family

ID=26889330

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60129799T Expired - Lifetime DE60129799T2 (de) 2000-03-31 2001-03-30 Verfahren zur steigerung des haarwuchses durch wnt polypeptid

Country Status (9)

Country Link
US (4) US6924141B2 (de)
EP (1) EP1267616B1 (de)
JP (3) JP4813734B2 (de)
AT (1) ATE369144T1 (de)
AU (2) AU5301201A (de)
CA (1) CA2403817C (de)
DE (1) DE60129799T2 (de)
ES (1) ES2290125T3 (de)
WO (1) WO2001074164A1 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267616B1 (de) * 2000-03-31 2007-08-08 The General Hospital Corporation Verfahren zur steigerung des haarwuchses durch wnt polypeptid
AU2002238568A1 (en) * 2001-03-07 2002-09-19 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Identification and use of inhibitors of hair growth
US20050130181A1 (en) * 2001-05-18 2005-06-16 Sirna Therapeutics, Inc. RNA interference mediated inhibition of wingless gene expression using short interfering nucleic acid (siNA)
WO2003086334A1 (fr) * 2002-04-17 2003-10-23 Taisho Pharmaceutical Co., Ltd. Produit tonique pour la pousse de cheveux
AU2003254298A1 (en) * 2002-08-02 2004-02-23 Stratatech Corporation Species specific dna detection
US7785876B2 (en) 2002-11-14 2010-08-31 Aderans Research Institute, Inc. Cultivation of hair inductive cells
WO2004076642A2 (en) * 2003-02-27 2004-09-10 The Rockefeller University Method for modulating epithelial stem cell lineage
EP1673475B1 (de) 2003-10-10 2010-04-28 Deutsches Krebsforschungszentrum Zusammensetzungen für die diagnose und therapie von erkrankungen, die im zusammenhang mit einer anomalen expression von futrinen (r-spondinen) stehen
EP1743022A4 (de) * 2004-02-27 2008-02-06 Gen Hospital Corp Verfahren und zusammensetzungen für haarwachstum
US20060115460A1 (en) * 2004-08-30 2006-06-01 Naughton Gail K Compositions and methods comprising WNT proteins to promote repair of damaged tissue
AU2005279934A1 (en) * 2004-08-30 2006-03-09 Theregen, Inc. Compositions and methods of promoting hair growth
WO2006036179A2 (en) * 2004-09-21 2006-04-06 Rhode Island Hospital, A Lifespan-Partner Frizzled proteins and detection and treatment of cancer
WO2006036175A2 (en) * 2004-09-21 2006-04-06 Rhode Island Hospital, A Lifespan-Partner Wnt proteins and detection and treatment of cancer
US7850960B2 (en) * 2004-12-30 2010-12-14 University Of Washington Methods for regulation of stem cells
JP2008179540A (ja) * 2005-01-07 2008-08-07 Noevir Co Ltd 細胞分化、発生、増殖を制御する物質および該物質を含む細胞分化・発生・増殖調節剤
EP1844787A4 (de) * 2005-01-18 2011-10-19 Univ Kyoto Arzneimittel für die nervenzellregeneration
CA2964111A1 (en) * 2005-03-29 2006-10-05 The Trustees Of The University Of Pennsylvania Methods for generating new hair folicles, treating baldness, and hair removal
AU2012204059B2 (en) * 2005-03-29 2015-01-15 The Trustees Of The University Of Pennsylvania Methods for generating new hair follicles, treating baldness and hair removal
ES2525067T3 (es) * 2005-04-07 2014-12-17 The Trustees Of The University Of Pennsylvania Método de incremento de la función de un vector de AAV
US8227244B2 (en) * 2005-05-16 2012-07-24 The Rockefeller University Method for isolating dermal papilla cells and uses thereof
TW200800240A (en) 2005-11-22 2008-01-01 Aderans Res Inst Inc Hair follicle graft from tissue engineered skin
JP5386180B2 (ja) 2006-02-28 2014-01-15 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク 真皮細胞のコンパクト凝集のための方法
GB0605450D0 (en) 2006-03-17 2006-04-26 Intercytex Ltd Cell co-culture
EP2455111B1 (de) * 2006-06-27 2017-08-16 Shiseido Company, Limited Zellcluster mit mehreren zellarten aus dem soma mit fähigkeit zur bildung primitiver organähnlicher strukturen
JP2010504974A (ja) * 2006-09-28 2010-02-18 フォリカ，インコーポレーテッド 新しい毛嚢を生成させ毛髪を成長させる方法、キット、及び組成物
US7922688B2 (en) 2007-01-08 2011-04-12 Restoration Robotics, Inc. Automated delivery of a therapeutic or cosmetic substance to cutaneous, subcutaneous and intramuscular tissue regions
US8580236B2 (en) * 2007-03-19 2013-11-12 Richard P. De Maria Hair sustaining formulation
AU2008270972B2 (en) 2007-07-02 2013-10-24 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
JP5300273B2 (ja) * 2008-01-21 2013-09-25 株式会社 資生堂 ヒトＷｎｔ３ａ遺伝子形質転換細胞
US20100166824A1 (en) * 2008-01-30 2010-07-01 Histogen, Inc. Extracellular matrix compositions
EP2262891B1 (de) * 2008-01-30 2022-09-21 Histogen, Inc. Extrazelluläre-matrix-zusammensetzungen
US8535913B2 (en) * 2008-01-30 2013-09-17 Histogen, Inc. Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells
US8524494B2 (en) * 2008-01-30 2013-09-03 Histogen, Inc. Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro
US8530415B2 (en) * 2008-01-30 2013-09-10 Histogen, Inc. Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions
FR2936255B1 (fr) * 2008-09-19 2010-10-15 Galderma Res & Dev Modulateurs de fzd2 dans le traitement de l'alopecie
US8871711B2 (en) * 2008-11-12 2014-10-28 The Trustees Of The University Of Pennsylvania Fibroblast growth factor-9 promotes hair follicle regeneration after wounding
WO2010075286A1 (en) * 2008-12-24 2010-07-01 University Of Washington MOLECULAR ACTIVATORS OF THE Wnt/β-CATENIN PATHWAY
KR101198918B1 (ko) * 2009-09-01 2012-11-07 (주)케어젠 Ｗｎｔ１０?유래 펩타이드 및 그의 용도
WO2011049958A2 (en) * 2009-10-21 2011-04-28 Otonomy, Inc. Modulation of gel temperature of poloxamer-containing formulations
KR101209117B1 (ko) 2010-03-25 2012-12-06 (주)케어젠 변형된 ｗｎｔ１０?유래 펩타이드 및 그의 용도
ES2667532T3 (es) * 2010-06-18 2018-05-11 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Neogénesis del folículo piloso
BR112013014021A8 (pt) 2010-12-06 2017-10-03 Follica Inc Métodos para tratamento de calvície e promoção de crescimento de cabelos
WO2012174280A2 (en) 2011-06-15 2012-12-20 The Regents Of The University Of California Methods and compositions for modulating myofibroblast activities
EP2731625B1 (de) 2011-07-15 2018-04-18 OncoMed Pharmaceuticals, Inc. Rspo-bindende stoffe und ihre verwendung
KR101285259B1 (ko) 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
WO2014012007A2 (en) 2012-07-13 2014-01-16 Oncomed Pharmaceuticals, Inc. Rspo3 binding agents and uses thereof
CN105343073B (zh) * 2013-03-07 2018-05-04 中国科学院上海生命科学研究院 一种可用作Wnt信号途径激活剂的化合物及其制备与应用
US10478526B2 (en) 2013-05-03 2019-11-19 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Skin substitutes and methods for hair follicle neogenesis
US11142577B2 (en) 2014-09-12 2021-10-12 The Board Of Trustees Of The Leland Stanford Junior University WNT signaling agonist molecules
US10064937B2 (en) 2014-09-16 2018-09-04 Oncomed Pharmaceuticals, Inc. Treatment of dermal fibrosis
EP3242724A4 (de) * 2015-01-09 2018-08-22 The Board of Trustees of The Leland Stanford Junior University Durch r-spondin-agonisten vermittelter haarwuchs
EP3562827A1 (de) 2016-12-30 2019-11-06 Frequency Therapeutics, Inc. 1h-pyrrol-2,5-dion-verbindungen und verfahren zur verwendung davon zur induktion der selbsterneuerung von unterstützenden stamm-/vorläuferzellen
CN106727682A (zh) * 2017-01-20 2017-05-31 李玉红 一种用于治疗脱发的制剂
AU2018250591A1 (en) * 2017-04-11 2019-10-10 Frequency Therapeutics, Inc. Methods for hair follicle stem cell proliferation
EP3638239A4 (de) 2017-06-15 2021-03-10 Belite Bio, Inc Verfahren zur behandlung von rbp4-bedingten krankheiten mit triazolopyridinen
TWI841532B (zh) 2017-06-15 2024-05-11 開曼群島商貝利特生物股份有限公司 以稠合雙環吡唑治療代謝疾病之方法
EP3970695B1 (de) 2017-11-16 2025-01-01 Aivita Biomedical, Inc. Verwendung von zellmembrangebundenen signalisierungsfaktoren
EP3732201A4 (de) 2017-12-19 2022-04-20 Surrozen Operating, Inc. Wnt-surrogatmoleküle und deren verwendungen
US12006368B2 (en) 2017-12-19 2024-06-11 Surrozen Operating, Inc. Anti-frizzled antibodies and methods of use
CA3085785A1 (en) 2017-12-19 2019-06-27 Surrozen, Inc. Anti-lrp5/6 antibodies and methods of use
TWI665217B (zh) * 2018-03-07 2019-07-11 臺鹽實業股份有限公司 膠原蛋白衍生胜肽及其用於製備促進生髮組成物之用途
GB201816902D0 (en) 2018-10-17 2018-11-28 Hairclone Ltd Hair Rejuvenation
KR102242840B1 (ko) * 2019-04-04 2021-04-23 주식회사 비알팜 탈모 방지 또는 발모 촉진용 조성물
CN114364382A (zh) 2019-07-08 2022-04-15 倍亮生物有限责任公司 Rbp4抑制剂的制剂和使用方法
EP4100071A1 (de) * 2020-02-07 2022-12-14 King's College London Geweberegenerationspflaster
CA3198268A1 (en) 2020-11-16 2022-05-19 Surrozen Operating, Inc. Liver-specific wnt signal enhancing molecules and uses thereof
EP4347027A4 (de) * 2021-05-26 2025-04-09 Figene, LLC Verfahren und zusammensetzungen zur alopeziebehandlung mit fibroblasten und fibroblastenabgeleiteten produkten

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091173A (en) * 1989-06-29 1992-02-25 The University Of Dundee Hair growth composition
US5208145A (en) * 1991-05-06 1993-05-04 The Salk Institute For Biological Studies Assay for the presence, in cultured cells, of functional ligand-gated channels, and substances which enhance intracellular lithium accumulation by cultured cells via such channels
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US5780291A (en) 1993-12-22 1998-07-14 Merck & Co., Inc. Wnt-x growth factor polypeptide, DNA encoding same, and Wnt-x antibody
JP3573488B2 (ja) * 1994-04-11 2004-10-06 独立行政法人 科学技術振興機構 毛乳頭細胞の長期継代培養法
JP2991620B2 (ja) * 1994-08-30 1999-12-20 科学技術振興事業団 細胞活動の制御方法
AU7672996A (en) 1995-11-13 1997-06-05 Regents Of The University Of California, The Methods and compositions for hair growth promotion
DE19909251A1 (de) * 1998-02-21 1999-08-26 Max Delbrueck Centrum Mittel zur Therapie von menschlichen Erkrankungen, ausgehend von beta-Catenin, seine Herstellung und seine Verwendung
US6485972B1 (en) * 1998-10-15 2002-11-26 President And Fellows Of Harvard College WNT signalling in reproductive organs
US6159950A (en) 1998-10-16 2000-12-12 Cornell Research Foundation, Inc. Method of modulating hair growth
WO2000031134A1 (en) 1998-11-20 2000-06-02 Arch Development Corporation Regulation of hair follicle morphogenesis based on beta-catenin
EP1267616B1 (de) * 2000-03-31 2007-08-08 The General Hospital Corporation Verfahren zur steigerung des haarwuchses durch wnt polypeptid

Also Published As

Publication number Publication date
ES2290125T3 (es) 2008-02-16
CA2403817C (en) 2012-05-29
EP1267616B1 (de) 2007-08-08
CA2403817A1 (en) 2001-10-11
ATE369144T1 (de) 2007-08-15
US20040170611A1 (en) 2004-09-02
US20080286261A1 (en) 2008-11-20
DE60129799T2 (de) 2008-04-30
US20050271632A1 (en) 2005-12-08
US7175842B2 (en) 2007-02-13
EP1267616A1 (de) 2003-01-02
JP2011207908A (ja) 2011-10-20
WO2001074164A9 (en) 2002-01-10
US20020114772A1 (en) 2002-08-22
WO2001074164A1 (en) 2001-10-11
US6924141B2 (en) 2005-08-02
JP2004500407A (ja) 2004-01-08
JP4813734B2 (ja) 2011-11-09
AU2001253012B2 (en) 2006-02-23
JP5580252B2 (ja) 2014-08-27
AU5301201A (en) 2001-10-15
JP2014159471A (ja) 2014-09-04
US7985587B2 (en) 2011-07-26
JP5960749B2 (ja) 2016-08-02
EP1267616A4 (de) 2003-07-16

Similar Documents

Publication Publication Date Title
DE60129799D1 (de) Verfahren zur steigerung des haarwuchses durch wnt polypeptid
ATE453653T1 (de) Platinkomplexe zur behandlung von tumoren
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
DE60336326D1 (de) Verfahren zur herstellung des calciumsalzes von rosuvastatin
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
ATE428413T1 (de) Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
ATE471722T1 (de) Verfahren zur regulierung von angiogenese mit apelin-zusammensetzungen
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
DE602004018249D1 (de) Verfahren zur Dearomatisierung von Molkeprotein
DE60035693D1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
DE60037886D1 (de) Verfahren zur reinigung von rekombinanten proteinen, welche wachstumshormon antagonisten sind, mittels wässriger zweiphasen-extraktion
ATE406438T1 (de) Menschliches homolog aus der familie der metalloproteasen
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
DE60024997D1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE60325194D1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
ATE517629T1 (de) Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems
TR200102655T2 (tr) Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
MX2007005054A (es) Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax.
NO20055309D0 (no) Slurp-1 samrnensetninger og fremgangsmater for anvendelse derav
EP1734827A4 (de) Verfahren und zusammensetzungen zur behandlung von mit anomaler mikrosatellitenexpansion in verbindung stehenden krankheiten
ATE402948T1 (de) Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält
DE60119458D1 (de) Vorrichtung zur Feststellung der genetischen Sequenz von Biopolymeren
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition